论文部分内容阅读
Despite progress, combination chemotherapy was still restricted by limited effect and synergistic toxicities.In our study, we aimed to develop a co-delivery nanoparticulate system of pirarubicin (THP) and paclitaxel (PTX) (Co-AN) using human serum albumin to improve therapeutic effect and reduce systemic toxicities.